Skip to main content

MorphaBond ER FDA Approval History

Last updated by Judith Stewart, BPharm on Feb 22, 2021.

FDA Approved: Yes (Discontinued) (First approved October 2, 2015)
Brand name: MorphaBond ER
Generic name: morphine sulfate
Dosage form: Extended-Release Tablets
Company: Inspirion Delivery Sciences
Treatment for: Pain

MorphaBond ER (morphine sulfate) is an extended-release, abuse-deterrent, opioid analgesic for the treatment of pain severe enough to require daily, around-the-clock, long-term opioid treatment.

Development timeline for MorphaBond ER

Oct  5, 2015Approval FDA Approves MorphaBond (morphine sulfate) Extended-Release Tablets with Abuse-Deterrent Properties
Feb  9, 2015Inspirion Delivery Technologies Announces FDA Acceptance of MorphaBond ER (morphine sulfate extended-release) NDA

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.